Cadwalader, Wickersham & Taft grew its equity partner profits nearly 19 percent last year, in what the firm called a “validation” of its refocused strategy on a core client base of Wall Street banks, funds and corporations.
Profits per partner shot up by 18.6 percent to $2.51 million in 2017 as the equity partnership contracted by five partners to 40 partners, according to preliminary ALM reporting. Meanwhile, the firm’s revenue dropped 9.7 percent to $408.1 million, and overall lawyer head count dipped by about 15 percent, after the closure of three offices. Revenue per lawyer increased 6 percent to $1.09 million.
The firm’s success has attracted talented alums back to the firm, said managing partner Patrick Quinn. In the last week, he said, M&A dealmaker Christopher Cox and real estate finance expert Alan Lawrence have rejoined the firm’s equity partnership.
“Profits per partner being up 19 percent is some validation that we’re doing the right things,” Quinn said in an interview.
“It’s gratifying to see that the firm’s performance is reflecting the benefits of that more focused strategy,” he said, adding, “this is not a strategy about managing to the bottom line. It’s much more about making sure we’re the best law firm we can be to service our natural clients.”
Increased profitability is an “end product of good strategy,” Quinn said. “We’re just very, enthusiastic to continue the momentum.”
Cadwalader adopted its new strategic plan in late 2016, focusing its services on its core client base of financial institutions, large companies and funds, and leading to office closings in Hong Kong, Beijing and Houston, as well as a series of partner exits.
Quinn has previously said the firm had sought years ago to diversify too broadly, entering areas that were “not the practices that best served our natural client base.”
The firm’s head count, at 373 lawyers in 2017, is nearly half the size it was in 2006, when it counted about 721 lawyers, according to ALM data. Quinn said the firm’s 15 percent lower head count last year was “part of the strategy” and, “in refocusing the firm’s resources, we became temporarily smaller, but the strategy is very much about growth and we do expect 2018 to be a year of healthy growth for us.”
He added: “It’s really about redeploying resources into practices that are better suited to who our firm is and who our clients are.”
Still, Quinn won’t give any future head count goals. “Numbers drive you to do things that are not consistent with your strategy,” he said.
Quinn cited the firm’s smaller size as leading to its 10 percent revenue drop in 2017, its third year in a row of declining revenue. “We’re a smaller firm now than we were last year,” Quinn said, adding the firm “outperformed our own projections by a pretty significant margin.”
Familiar Faces, Partner Moves
Quinn also pointed to the return of Cox and Lawrence as a marker of the firm’s recent success.
Cox initially came to Cadwalader from Cahill Gordon & Reindel in 2012, becoming chairman of its corporate practice. In early 2016, he moved to New Jersey-based pharmaceutical product development company The Medicines Co. He remained a senior counsel at the firm until rejoining the partnership this month.
In a Bloomberg interview in 2016, Cox cited health issues and work-life balance considerations in his move outside Big Law. In an email to ALM on Tuesday, Cox said while he continues to serve as an employee at The Medicines Co., his role there has evolved, “allowing me to now devote the energy necessary to return to Cadwalader as a partner.” He added, “Over the last couple of years, I’ve had the opportunity to focus on my health. I’m now energized and excited to fully dedicate myself to growing my legal practice at Cadwalader.”
Lawrence practiced at Cadwalader for 16 years until leaving in 2009 for Arnold & Porter. Lawrence, whose important client relationships include Freddie Mac, represents institutional lenders and funds in real estate financings and restructurings and investors in the acquisition, development, and operation of commercial properties.
In new hires last year, Cadwalader brought on litigators Kyle DeYoung and Todd Blanche and Ellen Holloman; as well as Kurt Oosterhouse in finance; Peter Morreale in capital markets; and David Teigman in executive compensation.
But Cadwalader saw more than a dozen partners leave in 2017, including Kenneth Wainstein, formerly co-chairman of the firm’s litigation department and chairman of the white-collar group who left for Davis Polk & Wardwell. Other departures included Bruce Bloomingdale, who left for Dechert; Johnny Chiu, now at Perkins Coie; Gregory Mocek, now at Allen & Overy; Richard Nugent, now at Jones Day; and Adam Summers, who joined Fried, Frank, Harris, Shriver & Jacobson.
Quinn said the firm had anticipated some departures in 2017. “We understood when we embarked on this new strategy that there were going to be some people who may not see themselves as essential to that strategy,” he said.
Just this year, Cadwalader saw a four-partner team going to Milbank, Tweed, Hadley & McCloy in London. “We’re in a very, very active lateral market,” Quinn said, but “we are extremely committed to London.”
In London, where Quinn said the firm just expanded its office space, revenue increased in 2017 to $49.6 million, about a 10 percent rise from 2016. Quinn said the firm’s London office is now interested in hiring in litigation, restructuring, finance, corporate and regulatory.
“We’re very bullish on growth for London,” he said.
Speaking on practice area strengths in 2017, Quinn said the firm saw success across the board, including in corporate, capital markets, finance, real estate and litigation. In particular, Quinn said the firm’s well-known structured products and securitization practice “had an extremely strong year.” The firm said it closed 189 CLO transactions in 2017, valued at more than $86 billion. Cadwalader said it also dominated the field of firms that advised issuers and underwriters of commercial mortgage-backed securities offerings.
In its corporate department last year, Cadwalader represented Marcato Capital Management LP, a San Francisco-based investment manager, on multiple matters, including in a proxy contest with Buffalo Wild Wings and in connection with its investment in the company that makes Uggs boots. With Cox’s ties to the company, Cadwalader represented The Medicines Co. in its agreement to sell its infectious disease business unit to Melinta Therapeutics Inc. for $270 million.
In real estate, Cadwalader represented lenders in a $1.55 billion mortgage loan secured by Caesars Palace Las Vegas in connection with the spinoff of VICI Properties Inc., a newly formed REIT, from Caesars Entertainment Operating Co. Inc. in its emergence from Chapter 11 bankruptcy.
Cadwalader continues to represent one of the largest creditors of Puerto Rico in the U.S. territory’s restructuring of about $73 billion of outstanding bond debt.
On the litigation front, Cadwalader partner Jodi Avergun was appointed to oversee McKesson’s $150 million settlement and compliance agreement with the Justice Department and Drug Enforcement Administration related to a federal probe into the company’s distribution of oxycodone and hydrocodone.
And starting in 2017, Quinn said, the firm began partnering with in-house lawyers from clients such as Goldman Sachs, JPMorgan Chase, Morgan Stanley and other banks in staffing work on pro bono matters. “It’s about building a deeper and stronger relationship with the clients and that really seems to resonate with the clients, It’s great for us too,” Quinn said.